Cargando…
The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes
BACKGROUND: Circulating endocannabinoid levels are increased in obesity and diabetes. We have shown that fatty acid amide hydrolase (FAAH, an endocannabinoid hydrolysing enzyme) in subcutaneous adipose tissue positively correlates with BMI in healthy volunteers. The aim of the present study was to i...
Autores principales: | Cable, Jemma C, Tan, Garry D, Alexander, Stephen PH, O'Sullivan, Saoirse E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995979/ https://www.ncbi.nlm.nih.gov/pubmed/24593280 http://dx.doi.org/10.1186/1476-511X-13-43 |
Ejemplares similares
-
The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans
por: Cable, Jemma C, et al.
Publicado: (2011) -
Endocannabinoids in aqueous humour of patients with or without diabetes
por: Richardson, Patrick, et al.
Publicado: (2020) -
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2016) -
Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
por: O'Sullivan, Saoirse E., et al.
Publicado: (2009) -
Endocannabinoids modulate human blood–brain barrier permeability in vitro
por: Hind, William H, et al.
Publicado: (2015)